NorthWest Biotherapeutics Inc (NWBO)

[gnawkz]

Thanks for the analysis on cost.

Unfortunately, from my understanding, manufactured personalized cancer treatments cannot be compared to those costs listed on the report. A number of recent articles have appeared that showed manufacturing costs for JUNO and KITE therapies will range between $50K to $150K per patient alone. That doesn't even include all of the other overhead costs such as recruiting, screening, enrollment, administrative, and other costs.

I don't believe the $42K average for a Phase III trial or the $65K for an Oncology Phase III trial in the report is comparable to the cost of a Phase III personalized therapy that requires manufacturing. NWBO is a 1st mover in this area, thus have very little comparables.

Let me know if I am missing something.